LONA Q3 2024 Earnings — LeonaBio, Inc. Revenue & Financial Results | Market Cap Arena

LONALeonaBio, Inc.

$26M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$30M

Net Income

-$29M

EPS (Diluted)

$-7.50

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$86M

Total Liabilities

$29M

Stockholders' Equity

$58M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$30M	-$35M	+15.5%
Net Income	-$29M	-$33M	+12.8%